Samuel Mackintosh
Concepts (490)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 22 | 2025 | 329 | 2.110 |
Why?
| | Proteome | 16 | 2025 | 171 | 2.060 |
Why?
| | Histones | 12 | 2025 | 314 | 1.480 |
Why?
| | Chromatin | 8 | 2025 | 139 | 0.860 |
Why?
| | Saccharomyces cerevisiae Proteins | 7 | 2019 | 139 | 0.700 |
Why?
| | DNA-Binding Proteins | 7 | 2021 | 422 | 0.660 |
Why?
| | Animals | 39 | 2025 | 13505 | 0.580 |
Why?
| | Viral Nonstructural Proteins | 4 | 2021 | 61 | 0.560 |
Why?
| | Phosphoproteins | 3 | 2025 | 119 | 0.540 |
Why?
| | Transcription Factors | 9 | 2025 | 566 | 0.520 |
Why?
| | Saccharomyces cerevisiae | 6 | 2019 | 176 | 0.490 |
Why?
| | Mice | 24 | 2025 | 5949 | 0.490 |
Why?
| | Protein Interaction Mapping | 4 | 2020 | 37 | 0.480 |
Why?
| | Staphylococcus aureus | 4 | 2025 | 338 | 0.470 |
Why?
| | DNA Replication | 2 | 2025 | 160 | 0.460 |
Why?
| | DNA Helicases | 3 | 2021 | 150 | 0.460 |
Why?
| | Ubiquitin-Protein Ligases | 3 | 2024 | 96 | 0.430 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2025 | 10 | 0.420 |
Why?
| | Bacterial Proteins | 4 | 2019 | 361 | 0.410 |
Why?
| | DNA | 4 | 2015 | 549 | 0.410 |
Why?
| | Septins | 2 | 2024 | 20 | 0.410 |
Why?
| | Cryptococcus neoformans | 2 | 2024 | 26 | 0.400 |
Why?
| | Interferon Type I | 2 | 2023 | 27 | 0.390 |
Why?
| | Protein Binding | 11 | 2025 | 667 | 0.390 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 134 | 0.390 |
Why?
| | Hepacivirus | 3 | 2010 | 106 | 0.380 |
Why?
| | Lysine | 3 | 2025 | 89 | 0.380 |
Why?
| | Fungal Proteins | 2 | 2024 | 117 | 0.380 |
Why?
| | G-Quadruplexes | 3 | 2019 | 77 | 0.370 |
Why?
| | Signal Transduction | 9 | 2025 | 1671 | 0.350 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2021 | 36 | 0.350 |
Why?
| | Blood Proteins | 2 | 2024 | 85 | 0.350 |
Why?
| | Melanoma | 3 | 2024 | 288 | 0.350 |
Why?
| | Protein Processing, Post-Translational | 6 | 2020 | 153 | 0.340 |
Why?
| | Virus Replication | 2 | 2015 | 150 | 0.340 |
Why?
| | Aging | 3 | 2024 | 701 | 0.340 |
Why?
| | Tandem Mass Spectrometry | 7 | 2020 | 251 | 0.330 |
Why?
| | Mass Spectrometry | 8 | 2021 | 292 | 0.330 |
Why?
| | Humans | 45 | 2025 | 52483 | 0.320 |
Why?
| | Oncogene Proteins, Fusion | 3 | 2025 | 61 | 0.320 |
Why?
| | Proteolysis | 4 | 2023 | 101 | 0.310 |
Why?
| | HEK293 Cells | 7 | 2025 | 229 | 0.300 |
Why?
| | Kidney | 2 | 2025 | 707 | 0.290 |
Why?
| | Cell Cycle Checkpoints | 2 | 2019 | 32 | 0.280 |
Why?
| | Antibodies, Monoclonal | 2 | 2025 | 481 | 0.280 |
Why?
| | Bone Resorption | 2 | 2022 | 302 | 0.270 |
Why?
| | Osteoclasts | 2 | 2022 | 428 | 0.260 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2020 | 187 | 0.260 |
Why?
| | Mice, Knockout | 7 | 2025 | 879 | 0.260 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2025 | 857 | 0.250 |
Why?
| | Brain Stem Neoplasms | 1 | 2025 | 7 | 0.240 |
Why?
| | Factor XI | 1 | 2025 | 4 | 0.240 |
Why?
| | Caenorhabditis elegans | 2 | 2016 | 139 | 0.240 |
Why?
| | Gene Silencing | 2 | 2023 | 118 | 0.240 |
Why?
| | BRCA1 Protein | 1 | 2025 | 34 | 0.240 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 1884 | 0.240 |
Why?
| | Co-Repressor Proteins | 2 | 2023 | 18 | 0.230 |
Why?
| | Homeodomain Proteins | 2 | 2025 | 80 | 0.230 |
Why?
| | Organ Preservation | 1 | 2025 | 32 | 0.230 |
Why?
| | Glioma | 1 | 2025 | 78 | 0.230 |
Why?
| | Glycine | 1 | 2025 | 75 | 0.230 |
Why?
| | Nuclear Proteins | 2 | 2016 | 245 | 0.230 |
Why?
| | Heart Bypass, Right | 1 | 2024 | 15 | 0.230 |
Why?
| | Glucuronidase | 1 | 2024 | 47 | 0.220 |
Why?
| | Staphylococcal Infections | 2 | 2025 | 285 | 0.220 |
Why?
| | Sirtuin 1 | 1 | 2024 | 29 | 0.220 |
Why?
| | Diastole | 1 | 2024 | 70 | 0.220 |
Why?
| | Phenylalanine | 1 | 2025 | 132 | 0.220 |
Why?
| | Arteriovenous Fistula | 1 | 2024 | 28 | 0.220 |
Why?
| | Pulmonary Veins | 1 | 2024 | 43 | 0.220 |
Why?
| | Chiroptera | 1 | 2023 | 4 | 0.220 |
Why?
| | Retroelements | 1 | 2023 | 13 | 0.220 |
Why?
| | Endogenous Retroviruses | 1 | 2023 | 7 | 0.210 |
Why?
| | Mediator Complex | 1 | 2023 | 4 | 0.210 |
Why?
| | Fontan Procedure | 1 | 2024 | 68 | 0.210 |
Why?
| | Stress, Physiological | 1 | 2024 | 183 | 0.210 |
Why?
| | Membrane Proteins | 2 | 2016 | 335 | 0.210 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2023 | 26 | 0.210 |
Why?
| | Viruses | 1 | 2023 | 25 | 0.210 |
Why?
| | Methylation | 5 | 2025 | 126 | 0.210 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 236 | 0.210 |
Why?
| | Arteriovenous Malformations | 1 | 2024 | 74 | 0.210 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2016 | 299 | 0.210 |
Why?
| | Cell Cycle Proteins | 2 | 2021 | 169 | 0.210 |
Why?
| | Pulmonary Artery | 1 | 2024 | 150 | 0.200 |
Why?
| | Methionine | 1 | 2024 | 136 | 0.200 |
Why?
| | Kidney Transplantation | 1 | 2025 | 192 | 0.200 |
Why?
| | Polycomb Repressive Complex 2 | 2 | 2021 | 48 | 0.200 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2022 | 9 | 0.200 |
Why?
| | Peripheral Nerve Injuries | 1 | 2022 | 14 | 0.200 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2023 | 47 | 0.200 |
Why?
| | Trans-Activators | 2 | 2019 | 135 | 0.200 |
Why?
| | Energy Metabolism | 1 | 2025 | 302 | 0.200 |
Why?
| | Cecum | 2 | 2021 | 61 | 0.200 |
Why?
| | Receptors, Transferrin | 1 | 2022 | 16 | 0.200 |
Why?
| | Epigenesis, Genetic | 4 | 2023 | 406 | 0.200 |
Why?
| | Ikaros Transcription Factor | 1 | 2022 | 5 | 0.200 |
Why?
| | Intellectual Disability | 1 | 2024 | 127 | 0.200 |
Why?
| | Sepsis | 1 | 2025 | 239 | 0.190 |
Why?
| | Osteogenesis Imperfecta | 2 | 2020 | 37 | 0.190 |
Why?
| | Histone Acetyltransferases | 2 | 2014 | 24 | 0.190 |
Why?
| | Cell Line, Tumor | 6 | 2025 | 1470 | 0.190 |
Why?
| | Cell Proliferation | 4 | 2021 | 1023 | 0.190 |
Why?
| | Mutation | 7 | 2020 | 1347 | 0.190 |
Why?
| | Liver Failure, Acute | 1 | 2022 | 56 | 0.190 |
Why?
| | DEAD-box RNA Helicases | 2 | 2019 | 34 | 0.190 |
Why?
| | T-Lymphocytes | 2 | 2021 | 340 | 0.190 |
Why?
| | Early Growth Response Protein 1 | 1 | 2021 | 34 | 0.180 |
Why?
| | Phosphofructokinase-1, Type C | 1 | 2021 | 3 | 0.180 |
Why?
| | YY1 Transcription Factor | 1 | 2021 | 7 | 0.180 |
Why?
| | End Stage Liver Disease | 1 | 2022 | 48 | 0.180 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2021 | 21 | 0.180 |
Why?
| | Polycomb-Group Proteins | 1 | 2021 | 8 | 0.180 |
Why?
| | Iron | 1 | 2022 | 127 | 0.180 |
Why?
| | Cadherins | 2 | 2019 | 62 | 0.180 |
Why?
| | Cell Line | 5 | 2023 | 1030 | 0.180 |
Why?
| | Uterine Artery | 1 | 2021 | 2 | 0.180 |
Why?
| | Neoplasms | 2 | 2021 | 1325 | 0.180 |
Why?
| | Lymphocyte Activation | 1 | 2021 | 172 | 0.180 |
Why?
| | Ozone | 1 | 2021 | 20 | 0.180 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2023 | 202 | 0.180 |
Why?
| | Apoptosis | 3 | 2021 | 1119 | 0.170 |
Why?
| | Transcriptional Activation | 4 | 2025 | 122 | 0.170 |
Why?
| | Disease Models, Animal | 5 | 2025 | 1478 | 0.170 |
Why?
| | Vanadates | 1 | 2020 | 7 | 0.170 |
Why?
| | Phosphotyrosine | 1 | 2020 | 6 | 0.170 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 146 | 0.170 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 62 | 0.170 |
Why?
| | Neoplasms, Experimental | 1 | 2020 | 114 | 0.170 |
Why?
| | Adenine | 2 | 2019 | 31 | 0.170 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 78 | 0.170 |
Why?
| | Infant Formula | 1 | 2021 | 147 | 0.160 |
Why?
| | Multiple Myeloma | 3 | 2021 | 3049 | 0.160 |
Why?
| | Extracellular Matrix Proteins | 1 | 2020 | 69 | 0.160 |
Why?
| | HeLa Cells | 4 | 2025 | 265 | 0.160 |
Why?
| | Liver Neoplasms | 1 | 2023 | 333 | 0.160 |
Why?
| | Molecular Chaperones | 1 | 2020 | 66 | 0.160 |
Why?
| | DNA Damage | 2 | 2024 | 305 | 0.160 |
Why?
| | Translocation, Genetic | 1 | 2021 | 265 | 0.160 |
Why?
| | Alanine Transaminase | 1 | 2020 | 122 | 0.160 |
Why?
| | Poly(A)-Binding Proteins | 1 | 2019 | 5 | 0.160 |
Why?
| | Carrier Proteins | 1 | 2021 | 313 | 0.160 |
Why?
| | Collagen Type I | 1 | 2020 | 83 | 0.160 |
Why?
| | Ribonucleoproteins | 1 | 2019 | 21 | 0.160 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 804 | 0.160 |
Why?
| | Repressor Proteins | 2 | 2019 | 155 | 0.160 |
Why?
| | Lymphoma, Mantle-Cell | 1 | 2019 | 18 | 0.160 |
Why?
| | Protein Kinases | 1 | 2019 | 72 | 0.160 |
Why?
| | Ruminococcus | 1 | 2019 | 7 | 0.160 |
Why?
| | Xenopus Proteins | 1 | 2019 | 29 | 0.160 |
Why?
| | Starch | 1 | 2019 | 11 | 0.160 |
Why?
| | Integrin alpha Chains | 1 | 2019 | 9 | 0.160 |
Why?
| | Oxidative Phosphorylation | 1 | 2019 | 46 | 0.150 |
Why?
| | Arsenic | 1 | 2019 | 22 | 0.150 |
Why?
| | Virulence Factors | 1 | 2019 | 80 | 0.150 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2021 | 203 | 0.150 |
Why?
| | Melanoma, Experimental | 1 | 2019 | 40 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2019 | 326 | 0.150 |
Why?
| | Computational Biology | 1 | 2020 | 212 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2022 | 202 | 0.150 |
Why?
| | Oligonucleotides | 3 | 2008 | 76 | 0.150 |
Why?
| | Antineoplastic Agents | 3 | 2022 | 1222 | 0.150 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 133 | 0.150 |
Why?
| | Peptide Hydrolases | 1 | 2018 | 63 | 0.150 |
Why?
| | Osteomyelitis | 1 | 2019 | 125 | 0.140 |
Why?
| | Protein Biosynthesis | 2 | 2019 | 258 | 0.140 |
Why?
| | Software | 1 | 2020 | 280 | 0.140 |
Why?
| | Antigens, CD | 1 | 2019 | 218 | 0.140 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 187 | 0.140 |
Why?
| | Host-Pathogen Interactions | 2 | 2016 | 144 | 0.140 |
Why?
| | Kinetics | 4 | 2019 | 626 | 0.140 |
Why?
| | Female | 15 | 2025 | 28171 | 0.140 |
Why?
| | Diet | 1 | 2021 | 587 | 0.140 |
Why?
| | Up-Regulation | 2 | 2016 | 454 | 0.140 |
Why?
| | Breast Neoplasms | 2 | 2016 | 1212 | 0.140 |
Why?
| | CTLA-4 Antigen | 1 | 2017 | 23 | 0.140 |
Why?
| | Male | 12 | 2025 | 26761 | 0.140 |
Why?
| | Histone Code | 1 | 2017 | 32 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2017 | 41 | 0.130 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 19 | 0.130 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2016 | 39 | 0.130 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 11 | 0.130 |
Why?
| | 3' Untranslated Regions | 1 | 2016 | 55 | 0.130 |
Why?
| | Mitochondria, Liver | 1 | 2017 | 69 | 0.130 |
Why?
| | Neoplasm Proteins | 2 | 2016 | 334 | 0.130 |
Why?
| | RNA, Messenger | 2 | 2019 | 1132 | 0.130 |
Why?
| | Butadienes | 1 | 2017 | 49 | 0.130 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2016 | 17 | 0.130 |
Why?
| | Mitosis | 1 | 2016 | 88 | 0.130 |
Why?
| | Muscles | 1 | 2016 | 107 | 0.130 |
Why?
| | Cytoplasmic Granules | 1 | 2016 | 21 | 0.130 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 312 | 0.130 |
Why?
| | Vesicular Transport Proteins | 1 | 2016 | 38 | 0.130 |
Why?
| | rab GTP-Binding Proteins | 1 | 2016 | 36 | 0.130 |
Why?
| | Whole-Body Irradiation | 1 | 2017 | 127 | 0.130 |
Why?
| | Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 7 | 0.130 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2016 | 9 | 0.130 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2017 | 111 | 0.130 |
Why?
| | Lysosomes | 1 | 2016 | 76 | 0.130 |
Why?
| | Cytoplasm | 1 | 2016 | 94 | 0.130 |
Why?
| | Autoantigens | 1 | 2016 | 53 | 0.130 |
Why?
| | Protein Structure, Tertiary | 4 | 2014 | 242 | 0.120 |
Why?
| | Recombinant Proteins | 3 | 2019 | 483 | 0.120 |
Why?
| | Viral Load | 1 | 2016 | 82 | 0.120 |
Why?
| | Tumor Microenvironment | 3 | 2025 | 256 | 0.120 |
Why?
| | Tumor Burden | 1 | 2016 | 136 | 0.120 |
Why?
| | Human papillomavirus 16 | 1 | 2016 | 44 | 0.120 |
Why?
| | Carcinogens | 1 | 2017 | 193 | 0.120 |
Why?
| | Antigens, Viral | 1 | 2015 | 43 | 0.120 |
Why?
| | Chromatography, Liquid | 4 | 2020 | 240 | 0.120 |
Why?
| | Rhadinovirus | 1 | 2015 | 22 | 0.120 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 151 | 0.120 |
Why?
| | Cell Differentiation | 4 | 2021 | 665 | 0.120 |
Why?
| | Endoplasmic Reticulum | 1 | 2016 | 111 | 0.120 |
Why?
| | Mice, SCID | 3 | 2021 | 182 | 0.120 |
Why?
| | Proteins | 1 | 2018 | 348 | 0.120 |
Why?
| | Time Factors | 4 | 2025 | 2968 | 0.120 |
Why?
| | Rats | 4 | 2025 | 3220 | 0.120 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 140 | 0.120 |
Why?
| | Acetylation | 3 | 2021 | 95 | 0.120 |
Why?
| | Collagen | 1 | 2016 | 211 | 0.120 |
Why?
| | Tetrahymena thermophila | 1 | 2014 | 3 | 0.120 |
Why?
| | Heterochromatin | 1 | 2014 | 4 | 0.120 |
Why?
| | Hippocampus | 1 | 2016 | 201 | 0.110 |
Why?
| | Protozoan Proteins | 1 | 2014 | 32 | 0.110 |
Why?
| | Genetic Loci | 1 | 2014 | 49 | 0.110 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2014 | 55 | 0.110 |
Why?
| | Cells, Cultured | 4 | 2020 | 1567 | 0.110 |
Why?
| | Papillomavirus Infections | 1 | 2016 | 173 | 0.110 |
Why?
| | RNA | 2 | 2023 | 168 | 0.110 |
Why?
| | Phosphorylation | 3 | 2023 | 528 | 0.110 |
Why?
| | Membrane Glycoproteins | 1 | 2014 | 244 | 0.100 |
Why?
| | Pancreatic Neoplasms | 1 | 2015 | 216 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2019 | 636 | 0.100 |
Why?
| | Alzheimer Disease | 1 | 2016 | 332 | 0.100 |
Why?
| | Gene Expression Profiling | 3 | 2023 | 1105 | 0.100 |
Why?
| | RNA Interference | 3 | 2016 | 181 | 0.090 |
Why?
| | Ligands | 3 | 2023 | 206 | 0.090 |
Why?
| | DNA Methylation | 1 | 2016 | 592 | 0.090 |
Why?
| | Animals, Newborn | 2 | 2023 | 362 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2019 | 339 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2016 | 807 | 0.090 |
Why?
| | Nevus, Pigmented | 1 | 2011 | 34 | 0.090 |
Why?
| | Jurkat Cells | 2 | 2021 | 28 | 0.090 |
Why?
| | Enhancer Elements, Genetic | 3 | 2021 | 58 | 0.090 |
Why?
| | Hypertension | 1 | 2016 | 565 | 0.090 |
Why?
| | Ovarian Neoplasms | 1 | 2014 | 459 | 0.090 |
Why?
| | Ubiquitination | 2 | 2024 | 47 | 0.080 |
Why?
| | Gene Deletion | 3 | 2016 | 272 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2016 | 490 | 0.080 |
Why?
| | Heat-Shock Response | 2 | 2020 | 28 | 0.080 |
Why?
| | Gene Expression Regulation, Bacterial | 3 | 2019 | 187 | 0.080 |
Why?
| | Movement | 1 | 2010 | 82 | 0.080 |
Why?
| | DNA, Viral | 1 | 2010 | 137 | 0.080 |
Why?
| | Bacteria | 2 | 2021 | 228 | 0.080 |
Why?
| | Albuminuria | 1 | 2009 | 49 | 0.080 |
Why?
| | Mice, Inbred NOD | 2 | 2021 | 92 | 0.080 |
Why?
| | Mitochondria | 2 | 2023 | 430 | 0.080 |
Why?
| | RNA Helicases | 1 | 2008 | 31 | 0.080 |
Why?
| | Virulence | 2 | 2019 | 167 | 0.070 |
Why?
| | Receptors, Cell Surface | 1 | 2009 | 118 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2016 | 1378 | 0.070 |
Why?
| | Acetaminophen | 2 | 2022 | 279 | 0.070 |
Why?
| | DNA Copy Number Variations | 2 | 2019 | 117 | 0.070 |
Why?
| | Biofilms | 2 | 2019 | 191 | 0.070 |
Why?
| | Cockayne Syndrome | 1 | 2006 | 3 | 0.070 |
Why?
| | Bloom Syndrome | 1 | 2006 | 4 | 0.070 |
Why?
| | Werner Syndrome | 1 | 2006 | 14 | 0.070 |
Why?
| | Disease Progression | 2 | 2020 | 871 | 0.070 |
Why?
| | Eukaryotic Cells | 1 | 2006 | 15 | 0.070 |
Why?
| | MCF-7 Cells | 2 | 2016 | 64 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2016 | 108 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 221 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 1563 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 213 | 0.060 |
Why?
| | Mutation, Missense | 2 | 2021 | 108 | 0.060 |
Why?
| | Skin Neoplasms | 1 | 2011 | 505 | 0.060 |
Why?
| | Recombination, Genetic | 1 | 2006 | 109 | 0.060 |
Why?
| | Spectrophotometry | 1 | 2005 | 32 | 0.060 |
Why?
| | Dimerization | 1 | 2005 | 51 | 0.060 |
Why?
| | Cytokines | 2 | 2021 | 623 | 0.060 |
Why?
| | Spheroids, Cellular | 1 | 2025 | 27 | 0.060 |
Why?
| | Papio anubis | 1 | 2025 | 5 | 0.060 |
Why?
| | Origin Recognition Complex | 1 | 2025 | 6 | 0.060 |
Why?
| | Papio | 1 | 2025 | 21 | 0.060 |
Why?
| | Replication Origin | 1 | 2025 | 11 | 0.060 |
Why?
| | Crystallography, X-Ray | 1 | 2005 | 156 | 0.060 |
Why?
| | Adenosine Triphosphatases | 1 | 2005 | 91 | 0.060 |
Why?
| | Plasmids | 1 | 2005 | 163 | 0.060 |
Why?
| | Genome, Viral | 1 | 2005 | 83 | 0.060 |
Why?
| | Rats, Inbred Lew | 1 | 2025 | 48 | 0.060 |
Why?
| | Protein Conformation | 1 | 2005 | 176 | 0.060 |
Why?
| | Glucose Tolerance Test | 1 | 2025 | 60 | 0.060 |
Why?
| | Stromal Cells | 1 | 2025 | 79 | 0.060 |
Why?
| | Blood Coagulation | 1 | 2025 | 64 | 0.060 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2019 | 51 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2025 | 115 | 0.060 |
Why?
| | Cell Membrane | 1 | 2005 | 245 | 0.060 |
Why?
| | Models, Molecular | 1 | 2005 | 348 | 0.060 |
Why?
| | Models, Statistical | 1 | 2005 | 230 | 0.060 |
Why?
| | Blotting, Western | 1 | 2005 | 590 | 0.060 |
Why?
| | Jamaica | 1 | 2023 | 7 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 10 | 0.050 |
Why?
| | S-Adenosylmethionine | 1 | 2024 | 62 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2025 | 552 | 0.050 |
Why?
| | Hepatitis B virus | 1 | 2023 | 24 | 0.050 |
Why?
| | Genome | 1 | 2023 | 62 | 0.050 |
Why?
| | Organoids | 1 | 2023 | 39 | 0.050 |
Why?
| | Adhesins, Bacterial | 1 | 2003 | 28 | 0.050 |
Why?
| | Microvessels | 1 | 2023 | 31 | 0.050 |
Why?
| | Homocysteine | 1 | 2024 | 126 | 0.050 |
Why?
| | Models, Biological | 1 | 2006 | 735 | 0.050 |
Why?
| | Histone Deacetylases | 1 | 2023 | 51 | 0.050 |
Why?
| | Sural Nerve | 1 | 2022 | 7 | 0.050 |
Why?
| | DNA, Bacterial | 1 | 2003 | 176 | 0.050 |
Why?
| | Nerve Regeneration | 1 | 2022 | 20 | 0.050 |
Why?
| | Peripheral Nerves | 1 | 2022 | 44 | 0.050 |
Why?
| | Reference Values | 2 | 2016 | 313 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2022 | 39 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2022 | 71 | 0.050 |
Why?
| | Hepatocytes | 1 | 2023 | 190 | 0.050 |
Why?
| | Young Adult | 3 | 2016 | 4329 | 0.050 |
Why?
| | Antiviral Agents | 1 | 2023 | 178 | 0.050 |
Why?
| | Genomics | 1 | 2024 | 268 | 0.050 |
Why?
| | Substrate Specificity | 2 | 2015 | 193 | 0.050 |
Why?
| | Protein Stability | 1 | 2021 | 45 | 0.050 |
Why?
| | Vero Cells | 1 | 2021 | 44 | 0.050 |
Why?
| | Influenza A virus | 1 | 2021 | 20 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2021 | 95 | 0.050 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 25 | 0.040 |
Why?
| | Echocardiography | 1 | 2024 | 415 | 0.040 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2021 | 32 | 0.040 |
Why?
| | Promoter Regions, Genetic | 2 | 2019 | 467 | 0.040 |
Why?
| | Cryptococcosis | 1 | 2020 | 17 | 0.040 |
Why?
| | Models, Animal | 1 | 2021 | 234 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 73 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 42 | 0.040 |
Why?
| | Milk, Human | 1 | 2021 | 105 | 0.040 |
Why?
| | Genome, Human | 1 | 2021 | 121 | 0.040 |
Why?
| | Formaldehyde | 2 | 2011 | 51 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2020 | 57 | 0.040 |
Why?
| | Phosphopeptides | 1 | 2020 | 7 | 0.040 |
Why?
| | Swine | 1 | 2021 | 428 | 0.040 |
Why?
| | Adenosylhomocysteinase | 1 | 2020 | 9 | 0.040 |
Why?
| | Workflow | 1 | 2020 | 51 | 0.040 |
Why?
| | Ions | 1 | 2020 | 32 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2021 | 378 | 0.040 |
Why?
| | Alcohol Dehydrogenase | 1 | 2020 | 38 | 0.040 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2020 | 25 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2021 | 99 | 0.040 |
Why?
| | Drug Discovery | 1 | 2020 | 93 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2021 | 184 | 0.040 |
Why?
| | Databases, Genetic | 1 | 2020 | 83 | 0.040 |
Why?
| | Poly(A)-Binding Protein I | 1 | 2019 | 5 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 193 | 0.040 |
Why?
| | Oogenesis | 1 | 2019 | 18 | 0.040 |
Why?
| | Polyadenylation | 1 | 2019 | 19 | 0.040 |
Why?
| | Base Sequence | 2 | 2015 | 640 | 0.040 |
Why?
| | Xenopus laevis | 1 | 2019 | 40 | 0.040 |
Why?
| | Arsenate Reductases | 1 | 2019 | 3 | 0.040 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 10 | 0.040 |
Why?
| | Placenta | 1 | 2021 | 153 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2021 | 187 | 0.040 |
Why?
| | Binding Sites | 2 | 2014 | 377 | 0.040 |
Why?
| | Membrane Transport Proteins | 1 | 2019 | 46 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2022 | 1026 | 0.040 |
Why?
| | Lung | 1 | 2022 | 509 | 0.040 |
Why?
| | Oocytes | 1 | 2019 | 92 | 0.040 |
Why?
| | Piperidines | 1 | 2019 | 97 | 0.040 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 619 | 0.040 |
Why?
| | Heart Failure | 1 | 2024 | 565 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 128 | 0.040 |
Why?
| | Pyrazoles | 1 | 2019 | 114 | 0.040 |
Why?
| | Cell Cycle | 1 | 2019 | 230 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 205 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 460 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 132 | 0.040 |
Why?
| | Drug Overdose | 1 | 2020 | 163 | 0.040 |
Why?
| | Pyrimidines | 1 | 2019 | 199 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2018 | 89 | 0.040 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 82 | 0.030 |
Why?
| | Dexamethasone | 1 | 2020 | 438 | 0.030 |
Why?
| | Electron Transport Complex III | 1 | 2017 | 6 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 96 | 0.030 |
Why?
| | Macaca mulatta | 1 | 2017 | 92 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 2017 | 22 | 0.030 |
Why?
| | Retinoblastoma-Binding Protein 2 | 1 | 2016 | 6 | 0.030 |
Why?
| | CDC2 Protein Kinase | 1 | 2016 | 16 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 2017 | 24 | 0.030 |
Why?
| | Electron Transport Complex I | 1 | 2017 | 21 | 0.030 |
Why?
| | Ribonuclease III | 1 | 2016 | 14 | 0.030 |
Why?
| | Gamma Rays | 1 | 2017 | 49 | 0.030 |
Why?
| | Vinblastine | 1 | 2016 | 23 | 0.030 |
Why?
| | Tubulin Modulators | 1 | 2016 | 27 | 0.030 |
Why?
| | Cyclin D1 | 1 | 2016 | 57 | 0.030 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2017 | 184 | 0.030 |
Why?
| | Intermediate Filament Proteins | 1 | 2016 | 12 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2017 | 57 | 0.030 |
Why?
| | Detergents | 1 | 2016 | 15 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 2099 | 0.030 |
Why?
| | Endosomes | 1 | 2016 | 36 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2017 | 233 | 0.030 |
Why?
| | Thermodynamics | 1 | 2016 | 35 | 0.030 |
Why?
| | 14-3-3 Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | Codon, Nonsense | 1 | 2016 | 28 | 0.030 |
Why?
| | tau Proteins | 1 | 2016 | 27 | 0.030 |
Why?
| | Thiolester Hydrolases | 1 | 2016 | 6 | 0.030 |
Why?
| | Cyclophilins | 1 | 2016 | 9 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2016 | 60 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 370 | 0.030 |
Why?
| | X Chromosome | 1 | 2016 | 13 | 0.030 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2016 | 19 | 0.030 |
Why?
| | Vaccines, Subunit | 1 | 2016 | 15 | 0.030 |
Why?
| | Hydroxylation | 1 | 2016 | 62 | 0.030 |
Why?
| | Cell Survival | 1 | 2018 | 612 | 0.030 |
Why?
| | DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2016 | 15 | 0.030 |
Why?
| | Solubility | 1 | 2016 | 79 | 0.030 |
Why?
| | Mammals | 1 | 2016 | 61 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2018 | 421 | 0.030 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2016 | 38 | 0.030 |
Why?
| | Centrifugation | 1 | 2015 | 12 | 0.030 |
Why?
| | Endopeptidases | 1 | 2016 | 66 | 0.030 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 47 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2016 | 120 | 0.030 |
Why?
| | Adult | 3 | 2016 | 14161 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2015 | 27 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2016 | 171 | 0.030 |
Why?
| | DNA Transposable Elements | 1 | 2016 | 107 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 57 | 0.030 |
Why?
| | DNA, Mitochondrial | 1 | 2017 | 114 | 0.030 |
Why?
| | Infant | 1 | 2024 | 3733 | 0.030 |
Why?
| | Cell Death | 1 | 2016 | 177 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 84 | 0.030 |
Why?
| | Myofibroblasts | 1 | 2016 | 50 | 0.030 |
Why?
| | Lipids | 1 | 2016 | 155 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 123 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2016 | 93 | 0.030 |
Why?
| | Child, Preschool | 1 | 2024 | 4076 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2016 | 112 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2015 | 57 | 0.030 |
Why?
| | Homeostasis | 1 | 2016 | 201 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 357 | 0.030 |
Why?
| | Computer Simulation | 1 | 2016 | 290 | 0.030 |
Why?
| | Brain | 1 | 2023 | 1323 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2016 | 80 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2016 | 179 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 243 | 0.030 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2014 | 14 | 0.030 |
Why?
| | Glycomics | 1 | 2014 | 9 | 0.030 |
Why?
| | Micronucleus, Germline | 1 | 2014 | 2 | 0.030 |
Why?
| | DNA, Protozoan | 1 | 2014 | 11 | 0.030 |
Why?
| | Genotype | 1 | 2016 | 566 | 0.030 |
Why?
| | Glycosylation | 1 | 2014 | 106 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2014 | 125 | 0.030 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2014 | 70 | 0.030 |
Why?
| | Meiosis | 1 | 2014 | 74 | 0.030 |
Why?
| | Liver | 1 | 2020 | 1156 | 0.030 |
Why?
| | Vaccination | 1 | 2016 | 298 | 0.030 |
Why?
| | Pregnancy | 1 | 2021 | 2680 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 578 | 0.030 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 778 | 0.030 |
Why?
| | Phenotype | 1 | 2016 | 789 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2016 | 1201 | 0.030 |
Why?
| | Age Factors | 1 | 2016 | 1132 | 0.020 |
Why?
| | Bone and Bones | 1 | 2016 | 494 | 0.020 |
Why?
| | gp100 Melanoma Antigen | 1 | 2011 | 8 | 0.020 |
Why?
| | Fixatives | 1 | 2011 | 12 | 0.020 |
Why?
| | Child | 1 | 2024 | 7248 | 0.020 |
Why?
| | Tissue Fixation | 1 | 2011 | 36 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2011 | 38 | 0.020 |
Why?
| | Paraffin Embedding | 1 | 2011 | 52 | 0.020 |
Why?
| | Middle Aged | 2 | 2016 | 13028 | 0.020 |
Why?
| | Fluorescein | 1 | 2010 | 8 | 0.020 |
Why?
| | Streptavidin | 1 | 2010 | 16 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2010 | 44 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 46 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2010 | 97 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 88 | 0.020 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2009 | 9 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2016 | 3392 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 26 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2009 | 124 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2008 | 23 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2008 | 82 | 0.020 |
Why?
| | Diabetic Nephropathies | 1 | 2009 | 61 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 979 | 0.020 |
Why?
| | Blood Pressure | 1 | 2009 | 537 | 0.020 |
Why?
| | Consensus Sequence | 1 | 2003 | 22 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2003 | 74 | 0.010 |
Why?
| | Aged | 1 | 2016 | 10121 | 0.010 |
Why?
|
|
Mackintosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|